Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GD.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FD.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CM.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBC.1.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GC.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.40SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.34.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JD.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.79SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HP.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FU.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
EG.1.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.2.3.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.35SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.18SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
EL.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FU.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.4.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.84SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.97SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CH.1.1.14SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FE.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.17SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.5.3.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.95SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
ET.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.34SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.31SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.32SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
DS.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.15SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CV.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBKSYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.14.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBK.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CM.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.16SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.22SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.2.3.14SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.13SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
DV.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.11.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GJ.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HJ.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.101SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used